This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
ASCO GU 2022
ASCO GU 2022
Prostate Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Carcinoma
ASCO GU 2022 Prostate Cancer
Viewing 1-20 of 172 articles
ASCO GU 2022: A Path Forward: Addressing Disparities in Genitourinary Cancers
ASCO GU 2022: Treatment Outcomes for mCRPC Following Progression on Upfront ADT with Androgen Receptor Pathway Inhibitors for mCSPC
ASCO GU 2022: The TRAP Trial: Targeting Resistant Prostate Cancer, with or without DNA Repair Defects, Using the Combination of Ceralasertib and Olaparib
ASCO GU 2022: Real-World Health-Related Quality of Life and Caregiver Needs in Patients with mHSPC and mCRPC
ASCO GU 2022: Real-World Analyses of Major Adverse Cardiovascular Event Risk by Drug Class After Initiation of ADT
ASCO GU 2022: Real World Treatment Patterns Among Patients with mCRPC in the United States
ASCO GU 2022: Radiation Therapy in Localized Disease: Changing Horizons
ASCO GU 2022: Quantitative Assessment of PSMA Imaging Before and After 177Lu-PSMA-617 Treatment in a Phase I/II Trial
ASCO GU 2022: PROTEUS: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Apalutamide plus ADT Versus Placebo plus ADT Prior to Radical Prostatectomy in Patients with Localized or Locally Advanced High-Risk Prostate Cancer
ASCO GU 2022: Prevalence and Natural History of Non-Metastatic Castrate Resistant Prostate Cancer: A Population-Based Analysis
ASCO GU 2022: Preliminary Results of the "DUO" Observational Study: Quality of Life Assessment and Cross-Sectional Follow-up of Prostate Cancer Patients Treated with Degarelix
ASCO GU 2022: Preferences and Perceptions of Patients with mCRPC for Treatments and Biomarker Testing: An International Qualitative Study
ASCO GU 2022: Phase 1b Study of Tarlatamab, a Half-Life Extended Bispecific T-Cell Engager (HLE BiTE Immune Therapy) Targeting DLL3, in De Novo or Treatment Emergent Neuroendocrine Prostate Cancer
ASCO GU 2022: Phase 1 study of PSCA-targeted CAR T cell therapy for mCRPC
ASCO GU 2022: Novel Framework for Treatment Response Evaluation Using PSMA-PET/CT in Patients with mCRPC (RECIP): An International Multicenter Study
ASCO GU 2022: The Changing Landscape of Treatment and Survival for Men with Castration-Resistant Prostate Cancer in the Era of Novel Treatments
ASCO GU 2022: Disparities in Prostate Cancer: An Ethnicity Comparative Focus Among Hispanic Americans Versus Non-Hispanic Whites
ASCO GU 2022: The Effects of a Preference-Based Exercise Trial on Outcomes in Men on Androgen Deprivation Therapy (ADT) for Prostate Cancer Compared to an Exercise Randomized Controlled Trial of the Same Interventions
ASCO GU 2022: Outcomes of an Advanced Practice Nurse (APN)-Led Cancer Genetics Service
ASCO GU 2022: Evaluation of Compliance of Next-Generation Sequencing (NGS) Testing in Stage IV Genitourinary (GU) Cancer Patients and the Effect of an EHR Prompt (EP) on Increasing Frequency
1
2
3
4
5
6
7
8
9
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free